BRIEF-European Commission approves Parsabiv for adults on hemodialysis
November 11, 2016 at 16:08 PM EST
* European Commission approves Parsabiv (etelcalcetide) for the treatment of secondary hyperparathyroidism in adults on hemodialysis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|